How big is the Japan Oral Anti-Diabetic Drug Market?

The Japan Oral Anti-Diabetic Drug Market size is expected to reach USD 2.42 billion in 2024 and grow at a CAGR of 4.60% to reach USD 3.02 billion by 2029. Read More

What is the current Japan Oral Anti-Diabetic Drug Market size?

In 2024, the Japan Oral Anti-Diabetic Drug Market size is expected to reach USD 2.42 billion. Read More

Who are the key players in Japan Oral Anti-Diabetic Drug Market?

Sanofi, Eli Lilly, Astrazeneca, Janseen and Astellas are the major companies operating in the Japan Oral Anti-Diabetic Drug Market. Read More

What years does this Japan Oral Anti-Diabetic Drug Market cover, and what was the market size in 2023?

In 2023, the Japan Oral Anti-Diabetic Drug Market size was estimated at USD 2.31 billion. The report covers the Japan Oral Anti-Diabetic Drug Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Japan Oral Anti-Diabetic Drug Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029. Read More

Japan Oral Anti-Diabetic Drug Market Share

Statistics for the 2023 & 2024 Japan Oral Anti-Diabetic Drug market share, created by Mordor Intelligence™ Industry Reports. Japan Oral Anti-Diabetic Drug share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Market Share of Japan Oral Anti-Diabetic Drug Industry

The Japan oral anti-diabetes drug market is consolidated, with a few major manufacturers like Eli Lilly, AstraZeneca, Sanofi, and Janssen Pharmaceuticals having a global market presence. In contrast, the remaining manufacturers are confined to the other local or regional markets. Companies are focusing on innovations in diabetes drugs.